Shares of RHÖN-KLINIKUM Aktiengesellschaft (ETR:RHK - Get Free Report) traded up 2.4% on Wednesday . The stock traded as high as €12.90 ($14.02) and last traded at €12.90 ($14.02). 1,867 shares were traded during trading, a decline of 96% from the average session volume of 43,281 shares. The stock had previously closed at €12.60 ($13.70).
RHÖN-KLINIKUM Aktiengesellschaft Stock Performance
The company has a current ratio of 2.34, a quick ratio of 2.12 and a debt-to-equity ratio of 11.59. The company has a market cap of $863.53 million, a PE ratio of 18.43, a price-to-earnings-growth ratio of 26.77 and a beta of -0.13. The firm's fifty day moving average is €12.21 and its 200 day moving average is €12.19.
About RHÖN-KLINIKUM Aktiengesellschaft
(
Get Free Report)
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases.
Further Reading
Before you consider RHÖN-KLINIKUM Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and RHÖN-KLINIKUM Aktiengesellschaft wasn't on the list.
While RHÖN-KLINIKUM Aktiengesellschaft currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
